All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-37758118

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	37758118	A168V	S	S	Occult HBV Infection	G R I C L	View
2	37758118	E164G	S	S	Occult HBV Infection	G R I C L	View
3	37758118	F158L	S	S	Occult HBV Infection	G R I C L	View
4	37758118	F212C	S	S	Occult HBV Infection	G R I C L	View
5	37758118	G145R	S	S	Occult HBV Infection	G R I C L	View
6	37758118	K160N	S	S	Occult HBV Infection	G R I C L	View
7	37758118	L175S	S	S	Occult HBV Infection	G R I C L	View
8	37758118	M133I	S	S	Occult HBV Infection	G R I C L	View
9	37758118	S136Y	S	S	Occult HBV Infection	G R I C L	View
10	37758118	S167L	S	S	Occult HBV Infection	G R I C L	View
11	37758118	S210I	S	S	Occult HBV Infection	G R I C L	View
12	37758118	Y134F	S	S	Occult HBV Infection	G R I C L	View
13	37758118	D263E	RT	P	Occult HBV Infection	G R C L	View
14	37758118	I266V	RT	P	Occult HBV Infection	G R C L	View
15	37758118	L336M	RT	P	Occult HBV Infection	G R C L	View
16	37758118	Q267L	RT	P	Occult HBV Infection	G R C L	View
17	37758118	S317T	RT	P	Occult HBV Infection	G R C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.